|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0007603,
umls-concept:C0017742,
umls-concept:C0025598,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0040715,
umls-concept:C0178666,
umls-concept:C0178719,
umls-concept:C0206131,
umls-concept:C0279023,
umls-concept:C0337051,
umls-concept:C0442805,
umls-concept:C0599718,
umls-concept:C0599813,
umls-concept:C0599893,
umls-concept:C1280500,
umls-concept:C1509144,
umls-concept:C1522702
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1991-8-2
|
|
pubmed:abstractText |
To examine the cellular mechanism of the antihyperglycemic action of metformin, we studied its effect on various functional and molecular parameters involved in the pathogenesis of insulin resistance. Isolated rat adipocytes were incubated with or without metformin (1-100 micrograms/ml) for 2 h at 37 degrees C followed by an incubation with or without insulin (1.72 nM). Metformin treatment had no significant effect on basal 3-O-methylglucose uptake. In contrast, metformin increased insulin-stimulated glucose transport in a dose-dependent manner up to 43 +/- 7%. This effect was neither associated with a significant effect of metformin on trace insulin binding (1.74 +/- 0.20% without metformin vs. 1.89 +/- 0.30% with metformin; P greater than 0.05) nor with an effect of metformin on insulin-receptor kinase activity as measured by 32P incorporation into the 95,000-Mr beta-subunit of the insulin receptor and an exogenous substrate, histone 2B.(ABSTRACT TRUNCATED AT 250 WORDS)
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0012-1797
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
850-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1647995-3-O-Methylglucose,
pubmed-meshheading:1647995-Adipose Tissue,
pubmed-meshheading:1647995-Animals,
pubmed-meshheading:1647995-Cell Membrane,
pubmed-meshheading:1647995-Cells, Cultured,
pubmed-meshheading:1647995-Drug Synergism,
pubmed-meshheading:1647995-Glucose,
pubmed-meshheading:1647995-Insulin,
pubmed-meshheading:1647995-Kinetics,
pubmed-meshheading:1647995-Male,
pubmed-meshheading:1647995-Metformin,
pubmed-meshheading:1647995-Methylglucosides,
pubmed-meshheading:1647995-Monosaccharide Transport Proteins,
pubmed-meshheading:1647995-Protein Processing, Post-Translational,
pubmed-meshheading:1647995-Protein-Tyrosine Kinases,
pubmed-meshheading:1647995-Rats,
pubmed-meshheading:1647995-Rats, Inbred Strains,
pubmed-meshheading:1647995-Receptor, Insulin
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Association of Metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes.
|
|
pubmed:affiliation |
Department of Medicine, University-Hospital of Hamburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
